Physician
North Texas Family Care, PLLC
North Texas Family Care, PLLC was paid $64K by Medicaid between Aug 2020 and Sep 2023, across 14 billing codes. Its largest line is 87811, Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) — 37% of everything it billed.
33Billing provider infoNORTH TEXAS FAMILY CARE, PLLC
HURST, TX 76053
HURST, TX 76053
33aNPI1235509621assigned 09/29/2015
33bProvider typeFamily Medicine Physician
28Total paid$64K
24GClaims7,326
24DCodes billed14
24AFirst – last monthAug 2020 – Sep 2023
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#484 of 1,204
Median peer was paid$31K
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 224 | $2K | |
| 2021 | 2,210 | $27K | |
| 2022 | 4,454 | $30K | |
| 2023 | 438 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 37% | 2,712 | 1,762 | $23K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 234 | 177 | $7K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.9% | 391 | 243 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.4% | 313 | 292 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.0% | 635 | 549 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7.6% | 1,733 | 957 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.3% | 240 | 200 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.1% | 271 | 262 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.5% | 80 | 76 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 19 | 12 | $257.47 |
| 99000 | <1% | 39 | 25 | $197.30 | |
| 86328 | <1% | 21 | 20 | $90.46 |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROZEK, VAUGHN (OWNER)